SEC Form 4 · accession 0001123292-16-001556
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred E Cohen
Director
Period of report
Jan 11, 2016
Accepted (ET)
Jan 13, 2016 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 11, 2016 | M | 4,065 | $8.49 | A | 4,177 | D | |
| Common Stock | Jan 11, 2016 | M | 4,065 | $5.54 | A | 8,242 | D | |
| Common Stock | Jan 11, 2016 | M | 4,065 | $7.26 | A | 12,307 | D | |
| Common Stock | Jan 11, 2016 | M | 12,500 | $12.70 | A | 24,807 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.49 | Jan 11, 2016 | M | 4,065 | D | — | Jul 13, 2021 | Common Stock | 4,065 | 0 | D |
| Stock Option (right to buy)F1 | $5.54 | Jan 11, 2016 | M | 4,065 | D | — | Jul 10, 2022 | Common Stock | 4,065 | 0 | D |
| Stock Option (right to buy)F1 | $7.26 | Jan 11, 2016 | M | 4,065 | D | — | Jul 18, 2023 | Common Stock | 4,065 | 0 | D |
| Stock Option (right to buy)F1 | $12.70 | Jan 11, 2016 | M | 12,500 | D | — | May 15, 2024 | Common Stock | 12,500 | 0 | D |
Explanation of responses
- F1This option is fully vested and immediately exercisable.